PremiumThe FlyBiotech Alert: Searches spiking for these stocks today Allakos downgraded to Market Perform from Outperform at JMP Securities Piper downgrades Allakos to Neutral with only asset discontinued PremiumThe FlyAllakos announces results from its Phase 1 trial of AK006 JMP Securities healthcare analysts hold an analyst/industry conference call Allakos Reports Q3 2024 Results and Research Progress PremiumThe FlyAllakos announces results from AK006 study Allakos reports Q2 EPS (30c), consensus (33c) ALLK Upcoming Earnings Report: What to Expect? 
